
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2018 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 9.980.906 | 209.398 | 2 | ||
| 2020 | 0 | 6.000.000 | 60.000 | 1 | ||
| 2018 | 0 | 54.999.999 | 187.499 | 1 | ||
Total number of partners: 100
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 100
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-06-01 | Psychiatric Ratings using Intermediate Stratified Markers 2 | PRISM 2 | participant | 3.980.906 | 18 |
| 2021-06-01 | Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders | REALMENT | participant | 6.000.000 | 15 |
| 2020-01-01 | Prevention and Remediation of Insulin Multimorbidity in Europe | PRIME | participant | 6.000.000 | 23 |
| 2018-06-01 | Autism Innovative Medicine Studies – 2 – Trials | AIMS-2-TRIALS | participant | 54.999.999 | 48 |